94 related articles for article (PubMed ID: 9356832)
1. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Siberry GK; Abzug MJ; Nachman S; Brady MT; Dominguez KL; Handelsman E; Mofenson LM; Nesheim S; ; National Institutes of Health ; Centers for Disease Control and Prevention ; HIV Medicine Association of the Infectious Diseases Society of America ; Pediatric Infectious Diseases Society ; American Academy of Pediatrics
Pediatr Infect Dis J; 2013 Nov; 32 Suppl 2(0 2):i-KK4. PubMed ID: 24569199
[No Abstract] [Full Text] [Related]
2. Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children.
Siberry GK; Abzug MJ; Nachman S;
Pediatr Infect Dis J; 2013 Dec; 32(12):1303-7. PubMed ID: 24569304
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.
Masur H; Brooks JT; Benson CA; Holmes KK; Pau AK; Kaplan JE; ; ;
Clin Infect Dis; 2014 May; 58(9):1308-11. PubMed ID: 24585567
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics.
Rozenberg L; Haagmans BL; Neumann AU; Chen G; McLaughlin M; Levy-Drummer RS; Masur H; Dewar RL; Ferenci P; Silva M; Viola MS; Polis MA; Kottilil S
AIDS; 2009 Nov; 23(18):2439-50. PubMed ID: 19898214
[TBL] [Abstract][Full Text] [Related]
5. Late diagnosis of HIV infection at two academic medical centers: 1994-2004.
Jean-Jacques M; Walensky RP; Aaronson WH; Chang Y; Freedberg KA
AIDS Care; 2008 Sep; 20(8):977-83. PubMed ID: 18608072
[TBL] [Abstract][Full Text] [Related]
6. The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report.
Turner MD; Karlis V; Glickman RS
Anesth Prog; 2007; 54(3):115-7. PubMed ID: 17900210
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of HIV and AIDS among Central American, South American, and Caribbean immigrants to Houston, Texas.
Bouckenooghe AR; Shandera WX
J Immigr Health; 2002 Apr; 4(2):81-6. PubMed ID: 16228763
[TBL] [Abstract][Full Text] [Related]
8. Management of Opportunistic Infection Prophylaxis in the Highly Active Antiretroviral Therapy Era.
Furrer H; Cohort Study tS TSHIV
Curr Infect Dis Rep; 2002 Apr; 4(2):161-174. PubMed ID: 11927049
[TBL] [Abstract][Full Text] [Related]
9. Primary care for patients infected with human immunodeficiency virus: a randomized controlled trial.
Keitz SA; Box TL; Homan RK; Bartlett JA; Oddone EZ
J Gen Intern Med; 2001 Sep; 16(9):573-82. PubMed ID: 11556937
[TBL] [Abstract][Full Text] [Related]
10. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.
Marr KA; Lyons CN; Rustad TR; Bowden RA; White TC
Antimicrob Agents Chemother; 1998 Oct; 42(10):2584-9. PubMed ID: 9756759
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
Kaplan JE; Masur H; Holmes KK; ;
MMWR Recomm Rep; 2002 Jun; 51(RR-8):1-52. PubMed ID: 12081007
[TBL] [Abstract][Full Text] [Related]
12. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S32-43. PubMed ID: 8547510
[No Abstract] [Full Text] [Related]
13. Preface to the 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Service/Infectious Diseases Society of America.
Clin Infect Dis; 1997 Oct; 25 Suppl 3():S299-312. PubMed ID: 9356831
[No Abstract] [Full Text] [Related]
14. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.
Clin Infect Dis; 1997 Oct; 25 Suppl 3():S313-35. PubMed ID: 9356832
[No Abstract] [Full Text] [Related]
15. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).
Infect Dis Obstet Gynecol; 2000; 8(1):5-74. PubMed ID: 10741830
[No Abstract] [Full Text] [Related]
16. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
Clin Infect Dis; 2000 Apr; 30 Suppl 1():S29-65. PubMed ID: 10770913
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
